203 related articles for article (PubMed ID: 20215511)
21. Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies.
Decristofaro MF; Betz BL; Rorie CJ; Reisman DN; Wang W; Weissman BE
J Cell Physiol; 2001 Jan; 186(1):136-45. PubMed ID: 11147808
[TBL] [Abstract][Full Text] [Related]
22. BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1).
Williamson EA; Wolf I; O'Kelly J; Bose S; Tanosaki S; Koeffler HP
Oncogene; 2006 Mar; 25(9):1391-9. PubMed ID: 16331276
[TBL] [Abstract][Full Text] [Related]
23. SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation.
Banine F; Bartlett C; Gunawardena R; Muchardt C; Yaniv M; Knudsen ES; Weissman BE; Sherman LS
Cancer Res; 2005 May; 65(9):3542-7. PubMed ID: 15867346
[TBL] [Abstract][Full Text] [Related]
24. Temporal recruitment of transcription factors and SWI/SNF chromatin-remodeling enzymes during adipogenic induction of the peroxisome proliferator-activated receptor gamma nuclear hormone receptor.
Salma N; Xiao H; Mueller E; Imbalzano AN
Mol Cell Biol; 2004 Jun; 24(11):4651-63. PubMed ID: 15143161
[TBL] [Abstract][Full Text] [Related]
25. MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression.
Zaretsky JZ; Barnea I; Aylon Y; Gorivodsky M; Wreschner DH; Keydar I
Mol Cancer; 2006 Nov; 5():57. PubMed ID: 17083744
[TBL] [Abstract][Full Text] [Related]
26. Repression of GR-mediated expression of the tryptophan oxygenase gene by the SWI/SNF complex during liver development.
Inayoshi Y; Kaneoka H; Machida Y; Terajima M; Dohda T; Miyake K; Iijima S
J Biochem; 2005 Oct; 138(4):457-65. PubMed ID: 16272140
[TBL] [Abstract][Full Text] [Related]
27. Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor-coregulator interactions.
Wen J; Li R; Lu Y; Shupnik MA
Oncogene; 2009 Jan; 28(4):575-86. PubMed ID: 18997820
[TBL] [Abstract][Full Text] [Related]
28. No evidence for breast cancer susceptibility associated with variants of BRD7, a component of p53 and BRCA1 pathways.
Penkert J; Schlegelberger B; Steinemann D; Gadzicki D
Fam Cancer; 2012 Dec; 11(4):601-6. PubMed ID: 22864638
[TBL] [Abstract][Full Text] [Related]
29. BRD7, a novel PBAF-specific SWI/SNF subunit, is required for target gene activation and repression in embryonic stem cells.
Kaeser MD; Aslanian A; Dong MQ; Yates JR; Emerson BM
J Biol Chem; 2008 Nov; 283(47):32254-63. PubMed ID: 18809673
[TBL] [Abstract][Full Text] [Related]
30. BRCA1 interacts with dominant negative SWI/SNF enzymes without affecting homologous recombination or radiation-induced gene activation of p21 or Mdm2.
Hill DA; de la Serna IL; Veal TM; Imbalzano AN
J Cell Biochem; 2004 Apr; 91(5):987-98. PubMed ID: 15034933
[TBL] [Abstract][Full Text] [Related]
31. Characterization of a negative transcriptional element in the BRCA1 promoter.
MacDonald G; Stramwasser M; Mueller CR
Breast Cancer Res; 2007; 9(4):R49. PubMed ID: 17663789
[TBL] [Abstract][Full Text] [Related]
32. Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes.
Belandia B; Orford RL; Hurst HC; Parker MG
EMBO J; 2002 Aug; 21(15):4094-103. PubMed ID: 12145209
[TBL] [Abstract][Full Text] [Related]
33. BRCA1-mimetic compound NSC35446.HCl inhibits IKKB expression by reducing estrogen receptor-α occupancy in the IKKB promoter and inhibits NF-κB activity in antiestrogen-resistant human breast cancer cells.
Nathan S; Ma Y; Tomita YA; De Oliveira E; Brown ML; Rosen EM
Breast Cancer Res Treat; 2017 Dec; 166(3):681-693. PubMed ID: 28808806
[TBL] [Abstract][Full Text] [Related]
34. The SWI/SNF chromatin remodeling subunit BAF57 is a critical regulator of estrogen receptor function in breast cancer cells.
García-Pedrero JM; Kiskinis E; Parker MG; Belandia B
J Biol Chem; 2006 Aug; 281(32):22656-64. PubMed ID: 16769725
[TBL] [Abstract][Full Text] [Related]
35. BRD7 promoter hypermethylation as an indicator of well differentiated oral squamous cell carcinomas.
Balasubramanian A; Subramaniam R; Narayanan V; Annamalai T; Ramanathan A
Asian Pac J Cancer Prev; 2015; 16(4):1615-9. PubMed ID: 25743841
[TBL] [Abstract][Full Text] [Related]
36. Integrating ChIP-sequencing and digital gene expression profiling to identify BRD7 downstream genes and construct their regulating network.
Xu K; Xiong W; Zhou M; Wang H; Yang J; Li X; Chen P; Liao Q; Deng H; Li X; Li G; Zeng Z
Mol Cell Biochem; 2016 Jan; 411(1-2):57-71. PubMed ID: 26407966
[TBL] [Abstract][Full Text] [Related]
37. BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer.
Gorski JJ; James CR; Quinn JE; Stewart GE; Staunton KC; Buckley NE; McDyer FA; Kennedy RD; Wilson RH; Mullan PB; Harkin DP
Breast Cancer Res Treat; 2010 Aug; 122(3):721-31. PubMed ID: 19882246
[TBL] [Abstract][Full Text] [Related]
38. Cloning and characterization of the BRD7 gene promoter.
Liu H; Peng C; Zhou M; Zhou J; Shen S; Zhou H; Xiong W; Luo X; Peng S; Niu Z; Ouyang J; Li X; Li G
DNA Cell Biol; 2006 Jun; 25(6):346-58. PubMed ID: 16792505
[TBL] [Abstract][Full Text] [Related]
39. BRD7 is a candidate tumour suppressor gene required for p53 function.
Drost J; Mantovani F; Tocco F; Elkon R; Comel A; Holstege H; Kerkhoven R; Jonkers J; Voorhoeve PM; Agami R; Del Sal G
Nat Cell Biol; 2010 Apr; 12(4):380-9. PubMed ID: 20228809
[TBL] [Abstract][Full Text] [Related]
40. The BRG1- and hBRM-associated factor BAF57 induces apoptosis by stimulating expression of the cylindromatosis tumor suppressor gene.
Wang L; Baiocchi RA; Pal S; Mosialos G; Caligiuri M; Sif S
Mol Cell Biol; 2005 Sep; 25(18):7953-65. PubMed ID: 16135788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
